Concepedia

Differential Impact of Cilostazol on Restenosis According to Implanted Stent Type (from a Pooled Analysis of Three DECLARE Randomized Trials)

Seung‐Whan Lee, Jung‐Min Ahn, Seungbong Han, Gyung‐Min Park, Young–Rak Cho, Wooseok Lee, Jeong-Yoon Jang, Chang-Hee Kwon, Jong‐Young Lee, Won-Jang Kim,

The American Journal of Cardiology · 2013 · 11 citations · 21 references

DOI

Concepts

References

21

Quantifying heterogeneity in a meta‐analysis

Julian P. T. Higgins, Simon G. Thompson · Statistics in Medicine · 2002 · 36.7K citations

, , +10

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents

Sripal Bangalore, Sunil Kumar, Nicholas Amoroso et al. · Circulation · 2012 · 569 citations

, , +16

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

Stephen D. Wiviott, Elliott M. Antman, C. Michael Gibson et al. · American Heart Journal · 2006 · 327 citations

, , +17

Coronary Stent Restenosis in Patients Treated With Cilostazol

John S. Douglas, David R. Holmes, Dean J. Kereiakes et al. · Circulation · 2005 · 280 citations

, , +11

A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients

Clemens von Birgelen, Mounir W.Z. Basalus, Kenneth Tandjung et al. · Journal of the American College of Cardiology · 2012 · 248 citations · Full text

, , +17